Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.400
-0.030 (-0.68%)
Aug 15, 2025, 10:48 AM - Market open
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 368 employees as of December 31, 2024. The number of employees increased by 165 or 81.28% compared to the previous year.
Employees
368
Change (1Y)
165
Growth (1Y)
81.28%
Revenue / Employee
$552,899
Profits / Employee
-$181,894
Market Cap
259.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 368 | 165 | 81.28% |
| Dec 31, 2023 | 203 | -87 | -30.00% |
| Dec 31, 2022 | 290 | 12 | 4.32% |
| Dec 31, 2021 | 278 | -14 | -4.79% |
| Dec 31, 2020 | 292 | 8 | 2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VNDA News
- 14 days ago - Vanda Pharmaceuticals Inc. (VNDA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results - PRNewsWire
- 22 days ago - Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025 - PRNewsWire
- 2 months ago - Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S - PRNewsWire
- 2 months ago - Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting - PRNewsWire
- 3 months ago - Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025 - PRNewsWire
- 3 months ago - Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results - PRNewsWire